Search

Your search keyword '"Economides, Aris N"' showing total 21 results
Start Over "Economides, Aris N" Topic regeneron pharmaceuticals inc. -- intellectual property
21 results on '"Economides, Aris N"'

1. Patent Issued for Multifunctional alleles (USPTO 11319557)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Neomycin -- Reports -- Intellectual property, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2022 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Economides, Aris N. [...]

Published
2022

2. Patent Issued for Method For Making A Genetically Modified Mouse With An Inducible ACVR1 Mutation That Causes Ectopic Bone Formation (USPTO 10,470,444)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Genetically modified organisms -- Methods -- Genetic aspects, Amino acids -- Methods -- Genetic aspects, Pharmaceutical industry -- Intellectual property -- Methods, Proteins -- Methods -- Genetic aspects, House mouse -- Methods -- Genetic aspects, Animal genetic engineering, Biotechnology, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2019 NOV 27 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Economides, Aris N. (Tarrytown, NY); Hatsell, Sarah Jane (Nyack, NY), [...]

Published
2019

3. Patent Issued for Method for Detecting the Replacement of an Endogenous Allele with a Modified Allele by Homologous Recombination in a Mouse ES Cell (USPTO 9677129)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Biotechnology -- Methods, Anopheles -- Methods, Patents -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Patent/copyright issue, Biotechnology industry, Biological sciences, Business
Abstract

2017 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A patent by the inventors Economides, Aris N. (Tarrytown, NY); Murphy, Andrew J. (Croton-On-Hudson, [...]

Published
2017

4. Researchers Submit Patent Application, 'Compositions and Methods for Modifying Cells', for Approval

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Biochemistry -- Methods, Patents -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors ECONOMIDES, ARIS N. (Tarrytown, NY); Murphy, [...]

Published
2014

5. Patent Issued for Method for Genetically Modifying Mouse Embryonic Stem Cell by Homologous Recombination

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Embryonic stem cells -- Methods, Patents -- Methods, Mice -- Methods, Genetically modified organisms -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- A patent by the inventors Economides, Aris N. (Tarrytown, NY); Murphy, Andrew J. (Croton-on Hudson, NY); Valenzuela, David M. [...]

Published
2014

6. 'Methods of Modifying Eukaryotic Cells' in Patent Application Approval Process

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Patents -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Patent/copyright issue, Biological sciences, Health
Abstract

By a News Reporter-Staff News Editor at Life Science Weekly -- A patent application by the inventors Economides, Aris N. (Tarrytown, NY); Murphy, Andrew J. (Croton-on-Hudson, NY); Valenzuela, David M. [...]

Published
2013

7. Patent Issued for Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy (USPTO 11730150)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Genetic disorders -- Genetic aspects, Amino acids -- Intellectual property -- Reports -- Genetic aspects, Infants (Newborn) -- Reports, Physical fitness -- Reports, Pharmaceutical industry -- Intellectual property, Health
Abstract

2023 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2023

8. Patent Issued for Anti-ACVR1 antibodies and uses thereof (USPTO 11945872)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Antibodies, Pharmaceutical industry -- Intellectual property, Health
Abstract

2024 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Regeneron Pharmaceuticals Inc. (Tarrytown, New York, United States) has been issued patent number 11945872, according [...]

Published
2024

11. Researchers Submit Patent Application, 'Multispecific Antigen-Binding Molecules And Uses Thereof', for Approval (USPTO 20190309061)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Antigens, Physical fitness, Pharmaceutical industry -- Intellectual property, Obesity, Editors, Health
Abstract

2019 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2019

12. Researchers Submit Patent Application, 'Rodents With Conditional ACVR1 Mutant Alleles', for Approval (USPTO 20200229406)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Genes -- Genetic aspects, Gene mutation -- Genetic aspects, Amino acids -- Genetic aspects -- Intellectual property, Pharmaceutical industry -- Intellectual property, Proteins -- Genetic aspects, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 AUG 12 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Economides, Aris [...]

Published
2020

13. Patent Issued for Mice That Produce Hybrid Antibodies (USPTO 10,640,800)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Biotechnology, Antibodies, Biological products -- Intellectual property, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 MAY 20 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2020

14. Patent Issued for Mice That Produce Hybrid Antibodies (USPTO 10,584,364)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Biotechnology, Antibodies, Pharmaceutical industry -- Intellectual property, Biological products, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 MAR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Murphy, Andrew J. (Croton-On-Hudson, NY); Yancopoulos, George D. (Yorktown Heights, [...]

Published
2020

15. Patent Issued for Compositions And Methods For Modifying Cells (USPTO 10,344,299)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Pharmaceutical industry -- Intellectual property -- Methods, Biotechnology, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2019 JUL 24 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2019

16. Researchers Submit Patent Application, 'Rodents With Conditional ACVR1 Mutant Alleles', for Approval (USPTO 20190053473)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Pharmaceutical industry -- Intellectual property, Amino acids -- Genetic aspects, Proteins -- Genetic aspects, Genes -- Genetic aspects, Gene mutation -- Genetic aspects, Animal genetic engineering, Rodents, Biotechnology, Editors, Alleles, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2019 MAR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Economides, Aris [...]

Published
2019

17. Researchers Submit Patent Application, 'Rodents With Conditional ACVR1 Mutant Alleles', for Approval (USPTO 20190045760)

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Pharmaceutical industry -- Intellectual property, Amino acids -- Genetic aspects, Proteins -- Genetic aspects, Genes -- Genetic aspects, Gene mutation -- Genetic aspects, Animal genetic engineering, Rodents, Biotechnology, Editors, Alleles, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2019 MAR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Economides, Aris [...]

Published
2019

18. Patent Issued for Methods of Producing Hybrid Antibodies

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Patents -- Methods, Antibodies -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Biological products -- Methods, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- Regeneron Pharmaceuticals Inc. (Tarrytown, NY) has been issued patent number 8895801, according to news reporting originating out of Alexandria, [...]

Published
2014

19. Patent Issued for Genetically Modified Mice That Produce Hybrid Antibodies

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Genetically modified organisms, Patents, Antibodies, Pharmaceutical industry -- Intellectual property, Biological products, House mouse, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- A patent by the inventors Murphy, Andrew J. (Croton-on-Hudson, NY); Yancopoulos, George D. (Yorktown Heights, NY); Karow, Margaret (Santa [...]

Published
2014

20. Patent Issued for Method for Genetically Modifying Isolated Non-Human Mammalian Cell by Homologous Recombination

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Patents -- Methods, Genetically modified organisms -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) has been issued patent number 8846402, according to news reporting originating out of Alexandria, [...]

Published
2014

21. Patent Issued for Hybrid Antibodies Comprising Human Variable Regions and Mouse Constant Regions Produced in a Genetically Modified Mouse

Subjects
Regeneron Pharmaceuticals Inc. -- Intellectual property, Biological products, Viral antibodies, Patents, Antibodies, Mice, Genetically modified organisms, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- A patent by the inventors Murphy, Andrew J. (Croton-On-Hudson, NY); Yancopoulos, George D. (Yorktown Heights, NY); Karow, Margaret (Santa [...]

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results